DIM Supplement Alters Estradiol Patch Metabolism
A retrospective study found that DIM supplements significantly changed estrogen metabolism in postmenopausal women using estradiol patches, suggesting a potential drug-supplement interaction that may affect hormone therapy outcomes.
A study indicates that 3,3'-diindolylmethane (DIM), a supplement from cruciferous vegetables, notably alters urinary estrogen metabolite levels in postmenopausal women undergoing transdermal estradiol therapy. In a cohort of 1,458 women, 108 used DIM, displaying significant variations in estrogen profiles, with lower estrone and estriol but higher 2-hydroxyestrone and 2-hydroxyestradiol levels. The findings suggest that DIM may modify hormonal therapy's pharmacokinetics via cytochrome P450 enzyme induction, raising questions about clinical implications and the need for healthcare providers to inquire about supplement use.
1. DIM is derived from cruciferous vegetables. 2. Study included 1,458 postmenopausal women. 3. Significant estrogen profile differences were observed between DIM users and non-users. 4. DIM may induce cytochrome P450 enzymes, affecting hormone metabolism. 5. Importance of healthcare providers discussing supplement use with patients on MHT. 6. Future research needed to assess effects on therapeutic outcomes.